Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02465177
Other study ID # 13-3159
Secondary ID UL1TR001082
Status Recruiting
Phase
First received
Last updated
Start date July 2014
Est. completion date December 2021

Study information

Verified date February 2021
Source University of Colorado, Denver
Contact Diandra Reed, BS
Phone 3037246079
Email kathryne.reed@ucdenver.edu
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Unhealthy alcohol use is present in up to 38% of the 4 million patients admitted to an American intensive care unit (ICU) each year in the US. Despite the high prevalence of unhealthy alcohol use in ICU survivors, routine interventions targeted at reducing alcohol consumption, alcohol-related consequences, and illness related to alcohol are not currently part of the multidisciplinary approach to critical care. Although screening, brief intervention, and referral to treatment (SBIRT) has been described in several healthcare settings, it fails to address common characteristics of medical ICU survivors including high rates of alcohol use disorders, cognitive dysfunction, psychiatric comorbidities, and intimate involvement of friends and family. This study uses a qualitative approach to further understand the needs of medical ICU survivors with unhealthy alcohol use. The investigators hypothesize that there are common, modifiable barriers to improving alcohol-related outcomes


Recruitment information / eligibility

Status Recruiting
Enrollment 28
Est. completion date December 2021
Est. primary completion date November 2021
Accepts healthy volunteers No
Gender Male
Age group 18 Years to 100 Years
Eligibility Inclusion Criteria: - 18 years or older - admitted to the medical ICU - resolution of critical illness - resolution of delirium/agitation - AUDIT score 8 or greater for men, 5 or greater for women Exclusion Criteria: - unable to provide informed consent - prisoner - Unable to speak or write in English - Pregnant

Study Design


Locations

Country Name City State
United States University of Colorado Hospital Aurora Colorado

Sponsors (1)

Lead Sponsor Collaborator
University of Colorado, Denver

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in alcohol use Change in alcohol use as assessed using a Semi-structured qualitative interview 3 months
See also
  Status Clinical Trial Phase
Completed NCT02179749 - Mifepristone Treatment of Alcohol Use Disorder Phase 2
Completed NCT02113618 - Effect of Cognitive Training on Alcohol Use Outcomes N/A
Completed NCT01008280 - Baclofen to Reduce Alcohol Use in Veterans With HCV Phase 4
Active, not recruiting NCT02671019 - Effectiveness and Costs of Internet-based Treatment for Harmful Alcohol Use and Face-to-face Treatment in Addiction Care N/A
Completed NCT01751035 - Integrative Risk Reduction and Treatment for Teen Substance Use Problems and PTSD N/A
Active, not recruiting NCT03695653 - Messaging Interventions to Reduce Alcohol Problems Project N/A
Completed NCT02298751 - Exposure Therapy as Aftercare for Alcohol Use Disorder N/A
Completed NCT01642381 - Component Analysis for Motivational Interviewing N/A
Terminated NCT01566370 - Zonisamide for Heavy Drinkers With Bipolar Disorder Phase 2
Completed NCT02511808 - Adaptive Interventions for Problem Drinkers N/A
Completed NCT02384278 - Internet Based Cognitive Behavior Treatment for Alcohol Problems N/A
Completed NCT01613014 - ABT-436 for Alcohol Dependence Phase 2
Completed NCT02905162 - Understanding Longitudinal Clinical Outcomes and Post-release Retention in Care Among HIV-infected Prisoners in Lusaka, Zambia
Completed NCT02808468 - Brief Restructuring Intervention Following Trauma Exposure N/A
Completed NCT01692054 - Risk and Protective Factors of Children and Adolescents Who Were Hospitalized Due to Alcohol Intoxication N/A
Completed NCT02500602 - CAP: Doxazosin in the Treatment of Co-Occurring PTSD and Alcohol Use Disorders Phase 2
Active, not recruiting NCT02713217 - Implementing a Blended Care Model That Integrates Mental Healthcare and Primary Care Using Telemedicine and Care Management for Patients With Depression or Alcohol Use Disorder in Small Primary Care Clinics
Completed NCT02193256 - Varenicline + Prazosin for Heavy Drinking Smokers Early Phase 1
Completed NCT01172210 - Examining Common Substrates of Eating and Alcohol Use Disorders N/A
Completed NCT02885311 - Collaborative Care for Alcohol Use Disorders in the Patient-centered Medical Home Phase 1/Phase 2